The first version is focused to treat cartilage degeneration and degenerative joint diseases due to the size of the orthopaedic market which is one of the largest health market segments worldwide (valued at more than US$30 billion). Bones, cartilage and tendons are the most common type of tissues implanted, mostly in knee and hip arthroplasties surgeries, followed by heart valves and vascular segments, skin, and amniotic membrane tissues.

Competitive Advantages of 3D bioprinted tissues/components

The benefits of bioprinted tissues are remarkable, here are some examples considering the medical aspects:

  • Research carried out nowadays with two-dimensional (2D) cell cultures do not provide the expected results, as 2D cultures do not mimic the 3D structure of a living tissue. 3D bioprinting is the only available technology to effective print 3D cultures with human like tissue structures

  • In vitro creation of living tissues to reduce the use of animals and/or humans (Elimination of Pre-Clinical and Clinical trials)

  • Fast and cheaper development of drugs (12 years on average from the lab to the market, and more than $400 million cost in developing the majority of drugs)

  • Reduction and in many cases elimination of organ donors (future application)

  • Replicating native form and function of tissues

  • Reproducibility, automation and improved accuracy of the required tests (towards the regulatory process)

For more info, download our REGEMAT3D brochure Click for Download